Kiklin bixalomer regulatory update

Astellas said Japan approved an sNDA for Kiklin bixalomer capsules to include treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) who are not on dialysis. Previously, Kiklin was indicated only in CKD patients on dialysis. The product is a metal-free, non-absorbed polymeric phosphate-binding agent. ...